Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach. (2023)
Attributed to:
JPND GBA - personalised medicine for Parkinson disease: clinical and therapeutic stratification
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11910-023-01259-1
PubMed Identifier: 36881256
Publication URI: http://europepmc.org/abstract/MED/36881256
Type: Journal Article/Review
Volume: 23
Parent Publication: Current neurology and neuroscience reports
Issue: 4
ISSN: 1528-4042